This is a preview of subscription content, log in via an institution to check access.
Reference
Kopylov U, et al. The efficacy of vedolizumab for induction of clinical response and remission in anti-TNF naive patients with inflammatory bowel disease-a multicenter European real world experience. Journal of Crohn's and Colitis 11 (Suppl. 1): S264-S265 abstr. P366, 1 Feb 2017. Available from: URL: http://doi.org/10.1093/ecco-jcc/jjx002.491 [abstract] - Israel
Rights and permissions
About this article
Cite this article
Vedolizumab. Reactions Weekly 1696, 360 (2018). https://doi.org/10.1007/s40278-018-44548-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44548-3